ViraTherapeutics raises $4 mln
ViraTherapeutics GmbH said Wednesday it raised 3.6 million euros (US$4 million) in a first close of a Series A financing round. Boehringer Ingelheim Venture Fund and EMBL Ventures co-led the round, while Austria Wirtschaftsservice through its Venture-Capital-Initiative also invested. Innsbruck, Austria-based ViraTherapeutics is biopharmaceutical company developing cancer immunotherapies.
24 June 2015•5 mins read
